The Hemp Health and Innovation Symposium features a range of speakers discussing a variety of topics including medicinal uses of cannabis, health benefits, personal experiences, industrial and agricultural uses of hemp and more. These industry experts can broaden your knowledge and answer all your questions surrounding this game changing plant.
May 18 - 19, 2019 | Sydney, NSW
Damian Donoghue started SuperHealth seven years ago after he healed himself of Chronic Fatigue Syndrome with an organic wholefood diet, natural medicinal superfoods and cutting edge detoxification protocols.
Damian intensively researches how we develop dis-ease and how we can restore our physical, mental and emotional states to a place of wellness and harmony.
Over the years Damian has experimented with hundreds of different health products and self-healing regimes, discovering that many of the products available to us these days are synthetic, man-made, money making schemes, which have little beneficial effects on helping us heal our bodies.
Damian is super passionate about using cannabis to enhance human health and he loves sharing fun and practical ways to include cannabis in your family’s daily health regime.
CEO of Epilepsy Action Australia
Carol is a founding Director of the newly constituted Medicinal Cannabis Council. Carol has heard and seen the changes in people’s lives, including reduction in the severity and frequency of seizures, resulting from use of medicinal cannabis. She is an active advocate for people living with epilepsy.
Founder of BuddingTech and The Medical Cannabis Council of Australia
Adam studied Entrepreneurship at the Royal Melbourne Institute of Technology and Sweden's Jönköping University for international business and completed his bachelors in 2009. Over the past eight years, Adam has worked in multiple startups with a specific focus on education and community building technology.
In 2015, Adam became involved in the medical cannabis space due to his passion for the medicine and belief in innovation stimulating its growth. In 2016, Adam founded BuddingTech, Australia’s first medical cannabis advisory firm.
As CEO of BuddingTech, Adam has worked tirelessly developing networks and collaborations, including the facilitation and management of three student research projects on medical cannabis in conjunction with the University of Sydney Business School and MGC Pharmaceuticals, publishing Australia’s first Medical Cannabis White Paper.
Additionally, Adam also founded the Medical Cannabis Council, Australia's first national industry body to represent the medical cannabis industry in Australia. The Mission of the Medical Cannabis Council is to create a unifying voice for the medical cannabis industry in Australia, facilitating a framework of best practice and supporting the positioning of Australia as a world leader in research and production of safe, scientifically backed medical cannabis products.
Adam also works with Pharmacare, the largest private, Australian-owned consumer health, fitness, and consumer goods company in the country. The company is 100% Australian and family-owned, with offices located in Australia, Canada, US, United Kingdoms, China, Thailand, Singapore, Indonesia, Malaysia and New Zealand. Acting as the Cannabis Business Manager, Adam primary objective is to build a cannabis pipeline of products for the companies local and international distribution network.
Adam has also helped coordinate a series of medical cannabis conferences across Australia, most recently, Adam assisted with coordinating Australias largest medical cannabis in Sydney. Adam has spoken at several international events and has appeared in several major news outlets including the Sydney Morning Herald, Startup Smart, SBS, SkyNews, MJBizDaily, and other major publications.
Dr Teresa Towpik
Founder of MediHuanna
Dr Towpik has been a General Practitioner in Australia since 1993 and an advocate of medicinal cannabis since the law was amended and cannabis was legalised for medicinal use. Since then she has been studying the therapeutic properties of cannabis, how it works in the human body and the potential applications in General Practice, especially in the management of chronic debilitating pain.
In 2016, Dr Towpik founded MediHuanna, an organisation that provides science-based medicinal cannabis education for Health Professionals. Dr Towpik sees cannabis as a therapeutic agent that has huge potential in General Practice. Her goal is to change the stigma of cannabis through education, enabling it to be seen as an important medicine that should be integrated into modern medicine.
CEO of Textile & Composite Industries Pty Ltd
Charles Kovess is the CEO of Textile & Composite Industries Pty Ltd, inventors and owners of a unique hemp decorticator that is manufactured in Geelong. He has been heavily involved in global hemp markets since 2012, helping to expand understanding of possibilities for the hemp industry and how hemp can be a game-changer for agribusiness both in Australia, and globally. Charles earned his Bachelor of Laws with Honours and a Master of Laws, practised law successfully for 20 years, and since 1993 has established a global business as a professional speaker, author, educator, and executive coach.
President of the Industrial Hemp Association
It was James' passion for the environment that led to his first involvement in industrial hemp in 2009. His interest in all aspects of industrial hemp soon expanded and he has addressed many forums on the benefits of hemp for the economy, the environment, as food and as medicine.
James is the President of the Industrial Hemp Association of NSW, an organisation whose members have been prime movers in the legalisation of hemp as food. He is President of the Australian Industrial Hemp Alliance (AIHA) a national organisation representing members from all Australian states. He is also the Chair of the AIHA sub-committee on medicinal cannabis.
Dr Sanjay Nijhawan
Medical Director of Cannabis Access Clinics
Dr Sanjay Nijhawan is the Medical Director of Cannabis Access Clinics. Sanjay leads our team of doctors, engages with other senior clinicians, regulators and industry stakeholders. Sanjay splits his time between consulting with our patients, and ensuring we continue to uphold the highest standards of clinics governance and regulatory compliance in this new field of medicine in Australia. Sanjay is also Director and part owner of Specialist Medical Services, involved in the management of various private hospitals, Day Surgeries, Eye Centres and specialist clinics. Dr Nijhawan was previously Head of Clinical Development at Primary Healthcare. Earlier in his career Dr Sanjay was medical director and practice principal at a number of general medical practices around Australia.
Dr Natalie Beveridge
Researcher, CACOS Study
Jonathan leads our consulting team and is responsible for delivering project work to our clients. Jonathan has worked in healthcare since the pioneering days of the medicinal cannabis industry in Australia. Prior to this Jonathan had a 15 year career leading international businesses in the retail and supply chain sectors. Jonathan started as an analyst in the NOC team at News Limited and has an MBA from University of Technology Sydney and a BSC in Applied Physics and Electrical Engineering from University of Technology Sydney.
Health House International
Paul is a registered Australian and UK pharmacist. His company Health House was granted the first medicinal cannabis import license in Australia and he is currently distributing medicinal cannabis products to eligible patients. Over the last 30 years he has owned several retail pharmacies and worked both in Australia and the UK. In the last 3 years he has focussed on researching medicinal cannabis and has been to conferences, grow and manufacturing facilities and spoken to patients and prescribers in the US, Canada, Israel and recently South America. www.healthhouse.com.au
Co-Founder and Chief Executive Officer for Delta Tetra Consultancy
Prior to moving to Australia in 2015, Tim was prominently involved in the UK medical cannabis initiative, working with some of the industry’s global leaders and has acquired a comprehensive cannabis industry knowledge-set and network base. Tim has worked tirelessly to innovate and progress sensible approaches to cannabis legislation across Europe. This has led to an applicable and practical knowledge of the cannabis industry globally as well as a wealth of experience in medical cannabis and its relating nuances.
As Co-Founder and Chief Executive Officer for Delta Tetra Consultancy, Tim is responsible for the daily management of Delta Tetra and client care.
MHlthSc/DipBus/RN1/Dementia Consultant/Learning & Advisory
“Uplifting Dementia”: http://shimmeringspirit.wix.com/uplifting-dementia
Leah Bisiani has 35 years’ experience within aged /dementia care, establishing a highly skilled knowledge basis as a global leader in this field.
Her primary vision has focused on changing negative cultures and philosophies of care associated with people living with dementia, providing a voice that confronts current practice and advocates their rights. Leah has a passionate dedication towards Best Practice and is constantly researching and utilizing progressive and innovative approaches to obtain the highest possible quality of life for people living with dementia. She distributes and publishes her evidence-based research within the medical field, aged care sector and community, and sits on advisory boards worldwide.
Additionally, Leah advocates the therapeutic attributes of medicinal cannabis. Emphasised is, her focus on medicinal cannabis is unrelated and independent to her work with persons living with dementia. In 2015 Leah published a submission to the Victorian Law Reform discussing her support of medicinal cannabis as a healing medicine.
She has become a popular and prominent speaker at other foremost Australian and Global medicinal cannabis conferences, symposiums and summits, deliberating the promising therapeutic benefits of medicinal cannabis for the treatment of chronic intractable pain in the older population.
Her philosophy embodies Mahatma Ghand’s belief:
“Be the Change You Want to See in the World”.
Hemp Homes Australia
Gary has been involved in the Australian Hemp Industry since 1995. He is the owner of one of Australia’s long established and largest hemp retail business, the Margaret River HempCo. He is also owner/builder of Hemp Homes Australia.
His main advocacy is to promote the Australian Hemp Industry, by using only Australian Hemp Building products, whilst also supporting local industries.
Throughout his long involvement with Industrial Hemp, Gary’s philosophy is to promote the many benefits of Industrial Hemp. From the primary source of growing hemp, to its many products, including clothes, fabric, bodycare, food and now the building industry.
Beginning with his ownership of the retail business of the Margaret River HempCo, Gary, a builder by profession, has developed his knowledge, experience and expertise of the use of Industrial Hemp as a natural building resource.
His recent acquisition of a decortication facility in WA, has progressed his involvement, understanding and ability to show the process of the journey of the hemp crop from the field to its many and various finished products.
Dr Matua Jansen
Director of Cannabis Doctors Australia Pty Ltd
Co-founder, co-inventor and Chief Growth Officer at Growcentia
Symposium MC: Medical Cannabis Research Australia
Sharlene is a Medical Scientist (BAppSc -Medical Laboratory Science) and director of Medical Cannabis Research Australia who has been researching how Medical Cannabis may treat an ever-increasing array of disorders. Her university background in diagnostic pathology gives her the knowledge to understand disease processes in the human body.
She’s travelled to the US, Canada, Israel, Colombia and Chile to learn firsthand from the leading researchers in this new field of cannabinoid science. She’s passionate about sharing this knowledge by educating others under the banner of her charity Medical Cannabis Research Australia. She is committed to advocating for use and access to medical cannabis for patients in Australia as well as promoting more research to give clinicians the evidence they require to pursue this treatment for their patients, both in Australia and in the rest of the world.